Evaxion Biotech AS (EVAX)
3.97
+0.06
(+1.53%)
USD |
NASDAQ |
May 02, 13:21
Evaxion Biotech Debt to Equity Ratio: -1.825 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | -1.825 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.825
Minimum
Dec 2023
-1.825
Maximum
Dec 2023
-1.825
Average
-1.825
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Ascendis Pharma A/S | -3.744 |
DBV Technologies SA | -- |
Cellectis SA | 0.3968 |
Adaptimmune Therapeutics PLC | 0.00 |
Akari Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 12.89M |
Total Liabilities (Quarterly) | 17.63M |
Shareholders Equity (Quarterly) | -4.739M |
Current Ratio | 1.179 |